Search alternatives:
step decrease » sizes decrease (Expand Search), teer decrease (Expand Search), we decrease (Expand Search)
nn decrease » _ decrease (Expand Search), gy decreased (Expand Search), b1 decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
step decrease » sizes decrease (Expand Search), teer decrease (Expand Search), we decrease (Expand Search)
nn decrease » _ decrease (Expand Search), gy decreased (Expand Search), b1 decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
-
26801
AMPKα1 silencing and compound C blocks the inhibitory effects of AICAR on TGF-β1-induced myofibroblast activation.
Published 2014“…(B) Cultured NRK-49F cells were pre-incubated with compound C (1.0 mM, 2.5 mM, or 5.0 mM) for 30 mins. Then, these cells were stimulated with TGF-β1 (1 ng/mL) for 24 h before harvesting. …”
-
26802
mast cell quantification raw data.xlsx
Published 2023“…</p> <p><br></p> <p>1.jpg : apalstic anemia, magnification 4X, hematoxylin and eosin staining</p> <p>2.jpg: metachromatically stained mast cells, magnification 10X, Toluidine Blue staining</p> <p>3.jpg: metachromatically stained mast cells, magnification 20X, Toluidine Blue staining</p> <p>4.jpg: metachromatically stained mast cells, magnification 40X, Toluidine Blue staining</p> <p>5.jpg : MDS-h, hypoplastic marrow, magnification 4X, hematoxylin and eosin staining</p> <p>6.jpg: metachromatically stained mast cells, magnification 40X, Toluidine Blue staining</p> <p><br></p> <p>File: procedure of CD34 IHC staining</p> <p>this file provides the step by step procedure for CD34 IHC satining including te reagents used and time frames.…”
-
26803
Data_Sheet_1_Red Tide Events and Seasonal Variations in the Partial Pressure of CO2 and Related Parameters in Shellfish-Farming Bays, Southeastern Coast of Korea.docx
Published 2021“…During the entire study period, the air–sea CO<sub>2</sub> flux ranged from −14.2 to 3.7 mmol m<sup>–2</sup> d<sup>–1</sup>, indicating that the study area served as an overall sink for atmospheric CO<sub>2</sub>, and only functioned as a weak source during October. The mean annual CO<sub>2</sub> flux estimated from the correlation with temperature was −5.1 mmol m<sup>–2</sup> d<sup>–1</sup>. …”
-
26804
Additional file 6 of NSDHL contributes to breast cancer stem-like cell maintenance and tumor-initiating capacity through TGF-β/Smad signaling pathway in MCF-7 tumor spheroid
Published 2024“…Supplementary Material 6: Figure S6. A-83-01 (50 µM) decreased the phosphorylation of both SMAD2 and SMAD3 but did not show significant toxicity in MCF-7-spheroids. …”
-
26805
Supplementary files
Published 2025“…Forest plot was made using Review manager v5.4 with Odds ratio as measure effect. The inclusion study characteristics and findings from each study were summarised in an extraction table and then synthesised qualitatively. …”
-
26806
Supporting data for PhD thesis "Turbulence in Thermally-Stratified Boundary Layers over Idealized Urban Morphology"
Published 2024“…A recovery of -5/3 scaling occurs at scales smaller than buildings, decoupled from wave-like motions, as evidenced by a distinct spectral gap.…”
-
26807
Table_1_Optimizing dietary rumen-degradable starch to rumen-degradable protein ratio improves lactation performance and nitrogen utilization efficiency in mid-lactating Holstein da...
Published 2024“…Seventy-two Holstein dairy cows were randomly assigned to three groups (24 head/group), balanced for (mean ± standard deviation) days in milk (116 ± 21.5), parity (2.1 ± 0.8), milk production (42 ± 2.1 kg/d), and body weight (705 ± 52.5 kg). …”
-
26808
Data_Sheet_1_Optimizing dietary rumen-degradable starch to rumen-degradable protein ratio improves lactation performance and nitrogen utilization efficiency in mid-lactating Holste...
Published 2024“…Seventy-two Holstein dairy cows were randomly assigned to three groups (24 head/group), balanced for (mean ± standard deviation) days in milk (116 ± 21.5), parity (2.1 ± 0.8), milk production (42 ± 2.1 kg/d), and body weight (705 ± 52.5 kg). …”
-
26809
Comparison of MSH4 and RNF212 dynamics in WT and <i>Cdk2</i><sup><i>T160A</i></sup> spermatocytes.
Published 2020“…In early-pachytene WT and <i>Cdk2</i><sup><i>T160A</i></sup> spermatocytes, MSH4 foci can be observed along the length of paired axes (A and C, insets I–II and V–VI). MSH4 foci decrease in number as WT spermatocytes progress to mid-pachytene (B, insets III–IV). …”
-
26810
Quantitative PCR validation of mitochondrial genes.
Published 2012“…<p>A scatter plot with a line of best fit demonstrates that each gene in the PFC shows either increase or decrease in expression across age (qv <0.05). …”
-
26811
MCCD ventilation - Case-Figure 7
Published 2018“…The drop in the ventilation rate between 18:50 and 19:10 minutes was due to a leak in the airway circuit. …”
-
26812
The effects of stem cell parameters on the model predictions.
Published 2009“…As the leukemic cell population increases, the healthy cell population begins to decrease due to competition. Treatment is initiated once the leukemic cell burden has reached a threshold of cells, at which point the leukemic cell burden begins to decline. …”
-
26813
Sensitivity Analysis of Increasing Baseline Effectiveness of Self-Administered Antiretroviral Therapy.
Published 2013“…As the proportion of women who have a full response to self-administered HAART increases, there is a decrease in the proportion of women for whom DOT is cost-effective. …”
-
26814
Dynamic light scattering measurements of <i>in vitro</i> λ-DNA solutions of varying condensation state.
Published 2016“…At 50 mg/mL, the solution is above a threshold concentration of PEG 6000 and we observe a reduction in the λ-DNA diffusivity distribution, including a sharp decrease beyond the overlap concentration for PEG 6000 at 100 mg/mL (shades of yellow-orange). …”
-
26815
Sensitivity analysis.
Published 2021“…<p>The plot shows how much R<sub>t</sub> changes from a 10% increase (red) or 10% decrease (blue) in that model parameter relative to values in <a href="http://www.ploscompbiol.org/article/info:doi/10.1371/journal.pcbi.1009122#pcbi.1009122.t001" target="_blank">Table 1</a> (with τ<sub>Is</sub> = 0.2 and κ = 1). …”
-
26816
Total fluorescence of Z-RR-AMC and Z-FR-AMC cleavage by planaria lysate is reduced by inhibition of cathepsin activity.
Published 2016“…<p><b>(A)</b> Whole worm lysate was pre-incubated with 50μM E-64, a pan-cysteine protease inhibitor, before assaying with the fluorescent probe Z-RR-AMC. …”
-
26817
Regulation of nestin expression by thrombin and cell density in cultures of bone mesenchymal stem cells and radial glial cells-3
Published 2011“…Protein extracts were separated and revealed with anti-nestin and anti-actin antibodies. A decrease of nestin expression is apparent from an initial density of 50·10cells/cm(G). …”
-
26818
Real-Time Cytotoxicity Assay for Rapid and Sensitive Detection of Ricin from Complex Matrices
Published 2012“…Upon incubation with toxin the cell status and the cytotoxic effect were visualized using a characteristic cell index–time profile. For ricin, tested in concentrations of 0.06 ng/mL or above, a concentration-dependent decrease of cell index correlating with cytotoxicity was recorded between 3.5 h and 60 h. …”
-
26819
Supplementary Material for: Evolution of growth following anti-TNF-α therapy in paediatric Crohn’s disease: data from the Swiss IBD Cohort Study
Published 2025“…Patients treated with biologics exhibited significant height increase at T1 (p=0.022), with an overall flat height evolution (y=0.00x-0.31), whereas significant weight increase was maintained at T5 (p=0.0005, y=0.13x-0.50). Patients on immunomodulators showed a height increase (y=0.15x-0.20) and a significant weight increase at T2 (p=0.0047, y=0.10x-0.41). …”
-
26820
Data_Sheet_1_The timelines for the price and reimbursement authorization in Italy 2018–2020.pdf
Published 2022“…In 2020, the overall process duration for Off-patent pharmaceuticals procedures was equal to 129.8 average days [95% CI: (122.3–137.2)], with a median value of 108.0, whereas for In-patent pharmaceuticals procedures, it was equal to 283.1 average days [95% CI: (267.8–298.5)], with a median value of 284.0. Over time, the trend of the entire duration of the P&R process tended to decrease. …”